The paradox of microbial monitoring in a closed system—and how to address it
Although manual environmental monitoring remains the compendial standard for aseptic manufacturing, it presents a particular challenge in closed isolators—systems designed to separate the operator from the product.
Barrier integrity, unidirectional airflow, and vapor-phase decontamination are intended to create one of the most controlled environments in a facility. Yet environmental monitoring can require operators to intervene in that very environment to assess its state.
When routine monitoring becomes a root-cause investigation
Continuous viable air monitoring based on microbial growth typically involves exposing media for a defined period during a batch. In a long campaign, plates may be loaded and positioned before decontamination, remain in place throughout the cycle, be moved to their sampling locations through glove ports, stored for the duration of the campaign, and retrieved at the end.
Every one of these steps is a manipulation inside a Grade A environment—and each creates an opportunity for the monitoring process itself to generate a count that has nothing to do with product quality.
In some cases, the conditions for an investigation may already have been created before the media enters the isolator. Condensation can form on the lid or agar surface if the plates are not adequately protected with desiccant or are stored and transported incorrectly. Depending on the quality of the plates and how they are handled, they may also become damaged. Incoming inspection may detect these issues, but an operator loading plates through glove ports, under time pressure and with a decontamination cycle pending, may not.
Operator handling introduces additional risks. Exchanging plates through glove ports requires precise, fine-motor movements in a confined space. Dropped lids, contact with the plate rim, improper storage after sampling, and brief disruptions to first air are all possible outcomes.
The investigation that outlives the batch
This is where the cost begins to accumulate.
A plate may develop a colony—or become so dehydrated that it could no longer support microbial growth. Incubation may take seven days, followed by microbial identification. By then, the batch may already be in quarantine, and the conditions present during the exposure period are no longer directly observable.
The cause could be the media lot, pre-use storage conditions, airflow velocity across the exposed surface and the resulting dehydration, loading technique, transport time to the incubator, or variation between readers. Most of these factors leave no timestamp, and the events usually cannot be reconstructed with confidence.
As a result, teams may end up documenting a probable cause rather than determining the root cause. A CAPA focused on operator technique may then be implemented, while an unresolved risk is carried into the next campaign.
Growth-based active air and surface sampling remains essential. It provides colony counts, enables species identification, and supports trending against the facility’s microbial flora—capabilities that other techniques do not fully replace. Culture media is still needed for surface sampling and, according to many regulatory authorities, for microbial identification.
However, in highly controlled isolators running long campaigns, the handling of active air monitoring media can itself become the main source of risk.
Real-time, continuous microbial air monitoring
EU GMP Annex 1 is often viewed as a tightening of regulatory expectations. It can also be seen as an opportunity. The revision states that manufacturers “should consider the use of alternative methods, such as rapid microbiological methods,” provided that equivalence or superiority to an established method is demonstrated.
One established alternative is the biofluorescent particle counter (BFPC). It optically sizes airborne particles while assessing their intrinsic fluorescence, allowing it to classify particles in real time as biological particles—viable particle counts (VPC)—or as total particles (TPC). The results are time-stamped and available immediately.
The advantage is not simply a faster result. It is more actionable data.
When a potential contamination risk is detected, continuous real-time monitoring can help identify when the event occurred and support a timely response. It can also help demonstrate whether a corrective control is effective, rather than relying solely on a trend observed months later.
Keep the plate, remove the intervention
One of the first concerns raised by QC teams is often the requirement to report results in CFU. The Rapid-C+ all-in-one BFPC addresses this concern by incorporating a unit for conventional active air sampling.
The system can draw air through an isokinetic probe positioned at the critical location inside the isolator. The sample is then routed to an enclosed sampling head mounted outside the barrier system. The probe remains where the contamination risk exists, while the culture medium is positioned where the operator can access it without disrupting the isolator.
A standard 90 mm plate can still be exposed, incubated, identified, and included in environmental monitoring trends. However, replacing the plate becomes a straightforward task rather than an aseptic intervention.
Active air monitoring plates no longer need to remain inside the isolator throughout decontamination. Inspection and loading can be performed with good visibility, rather than through gloves or against the limited visibility of isolator glass.
Because the probe and detector use the same sample stream, the real-time and growth-based results are generated from the same air—not from two nearby but separate sampling locations.
A BFPC of this type can therefore supplement the existing quality system while removing much of the handling-related risk.
Fewer interventions, not fewer plates
The goal is not to eliminate plates. It is to reduce the number of reasons to open or intervene in the isolator.
By supplementing traditional environmental monitoring with real-time BFPC, manufacturers can preserve the value of growth-based methods while reducing avoidable interventions—and, consequently, the number of investigations triggered by the monitoring process itself.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special
offers from American Pharmaceutical Review delivered to your inbox!
Sign up now!